Key Financial Data Of Group

ONO PHARMACEUTICAL CO., LTD. - Filing #7722267

Concept As at
2018-06-30
2018-04-01 to
2018-06-30
2017-04-01 to
2018-03-31
As at
2018-03-31
As at
2017-06-30
2017-04-01 to
2017-06-30
Key financial data of group
Business results of group
Revenue
71,242,000,000 JPY
261,836,000,000 JPY
60,913,000,000 JPY
Profit (loss) before tax
19,428,000,000 JPY
63,922,000,000 JPY
15,796,000,000 JPY
Profit (loss), attributable to owners of parent
15,236,000,000 JPY
50,284,000,000 JPY
11,774,000,000 JPY
Comprehensive income
23,285,000,000 JPY
67,607,000,000 JPY
19,098,000,000 JPY
Equity attributable to owners of parent
541,508,000,000 JPY
524,390,000,000 JPY
505,073,000,000 JPY
Total assets
618,659,000,000 JPY
609,226,000,000 JPY
577,330,000,000 JPY
Basic earnings (loss) per share
29.64
97.00
22.31
Diluted earnings (loss) per share
29.63
96.99
22.31
Ratio of owners' equity to gross assets
0.875 xbrli:pure
0.861 xbrli:pure
0.875 xbrli:pure
Cash flows from (used in) operating activities
14,261,000,000 JPY
15,727,000,000 JPY
-18,728,000,000 JPY
Cash flows from (used in) investing activities
-6,887,000,000 JPY
-34,189,000,000 JPY
-3,229,000,000 JPY
Cash flows from (used in) financing activities
-9,409,000,000 JPY
-62,549,000,000 JPY
-31,898,000,000 JPY
Cash and cash equivalents
63,229,000,000 JPY
65,273,000,000 JPY
92,491,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.